US-based bioabsorbable scaffold company R3 Vascular has been granted investigational device exemption (IDE) approval by the ...

US-based bioabsorbable scaffold company, R3 Vascular, has been granted investigational device exemption (IDE) approval by the US Food and Drug Administration (FDA) to launch its ELITE-BTK pivotal ...

Royal Philips announced enrollment of the first patient in THOR, a United States investigational device exemption (IDE) clinica ...

R3 Vascular announced today that the FDA granted investigational device exemption (IDE) to evaluate its drug-eluting ...

The technology is integrated with company’s electroanatomical mapping system, which helps guide operators during AF ablation.

Envoy Medical (COCH) announces that its Investigational Device Exemption, IDE, application for its pivotal study of the Acclaim Fully Implanted ...

Akura Medical, a Shifamed portfolio company, announced today that the FDA granted its Katana system investigational device exemption (IDE).

Akura Medical, a Shifamed portfolio company focused on reshaping the landscape of venous thromboembolism (VTE) care, announced today the US Food and Drug Administration has approved its ...

Detailed price information for Envoy Medical Inc (COCH-Q) from The Globe and Mail including charting and trades.

The first clinical use of the Javelin peripheral intravascular lithotripsy (IVL) catheter (Shockwave Medical) for the treatment ...

Larry Jones, Johnson & Johnson Medtech’s chief information officer, will resign after more than three decades with the ...